BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 890-903 [PMID: 36816622 DOI: 10.3748/wjg.v29.i5.890]
URL: https://www.wjgnet.com/1007-9327/full/v29/i5/890.htm
Number Citing Articles
1
Marco Biolato, Maurizio Pompili. Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspectiveWorld Journal of Gastroenterology 2024; 30(31): 3635-3639 doi: 10.3748/wjg.v30.i31.3635
2
Hong-Jin Chen, Ting-Xiong Huang, Yu-Xi Jiang, Xiong Chen, Ai-Fang Wang. Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature reviewWorld Journal of Hepatology 2023; 15(12): 1258-1271 doi: 10.4254/wjh.v15.i12.1258
3
Xueyan Wang, Lei Gao, Haiyuan Li, Yanling Ma, Bofang Wang, Baohong Gu, Xuemei Li, Lin Xiang, Yuping Bai, Chenhui Ma, Hao Chen. Integrative analysis of multi-omics data identified PLG as key gene related to Anoikis resistance and immune phenotypes in hepatocellular carcinomaJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05858-5
4
Thang Viet Luong, Nam Van Duc Nguyen, Linh Duy Le, Hieu Nguyen Hoang Minh, Hai Nguyen Ngoc Dang. Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolizationWorld Journal of Gastroenterology 2024; 30(47): 4983-4990 doi: 10.3748/wjg.v30.i47.4983
5
Diomidis Kozyrakis, Vasilios Konstantinopoulos, Panagiotis Papaspyridakos, Anastasios Zarkadas, Dimitrios Bozios, Athanasios Karmogiannis, Georgios Haronis, Anna-Maria Konomi, Georgios Kallinikas, Konstantinos Safioleas, Despoina Mytiliniou, Athanasios Filios, Evaggelos Rodinos, Panagiotis Filios. Prostate artery embolization as an effective treatment for clinically significant prostate cancer‑related hemorrhage: A case report Experimental and Therapeutic Medicine 2024; 29(2) doi: 10.3892/etm.2024.12776